Cloudera Price Target is $16-$19 a Share

 Cloudera has a $16 to $19 price target.

Grower Generation

 The Fool owns shares of and recommends Grower Generation

3 Future 10 Baggers to Watch

 The Fool is out with a discussion of three companies that may turn into 10 baggers one day.  One of the companies is Magnite.   

On Criteo

 The Fool still owns shares of Criteo, which had a decent quarter in the COVID environment. 

Update on Aimmune Therapeutics

 The Fool is out with a small update on Aimmune Therapeutics.  They do not own shares. 

Crossing Wall Street's Buy List

Buy list is here. 

5 Reasons to Own Livongo Health

The Fool has an article on 5 Reasons to Own Livongo Health. 

PING Identity

The Fool owns shares of PING, which provides a similar service to Okta.  Gartner sees them as a leader behind Microsoft and Okta. 

3 Big Data Healthcare Stocks

From the Fool:

"I believe Health Catalyst has the most growth opportunities. If you're looking for the safest bet, Cerner is an entrenched dominant player in the industry, and it even began offering a dividend last year of $0.18 per quarter. Globus Medical splits the middle, offering plenty of growth with a lower level of risk."

Roku and Livongo

The Fool is high on Roku and Livongo Health